34 related articles for article (PubMed ID: 20150323)
1. Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Ahmad Hamdi AH; Dali AF; Mat Nuri TH; Saleh MS; Ajmi NN; Neoh CF; Ming LC; Abdullah AH; Khan TM
Front Pharmacol; 2017; 8():410. PubMed ID: 28744215
[TBL] [Abstract][Full Text] [Related]
2. Should bivalirudin replace heparin during percutaneous coronary interventions?
Antman EM
JAMA; 2003 Feb; 289(7):903-5. PubMed ID: 12588276
[No Abstract] [Full Text] [Related]
3. Why we do what we do? Making sense of antithrombotic therapy in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Brener SJ
JACC Cardiovasc Interv; 2010 Jun; 3(6):678-9. PubMed ID: 20630462
[No Abstract] [Full Text] [Related]
4. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ;
J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy to support primary PCI.
Morrow DA
N Engl J Med; 2008 May; 358(21):2280-2. PubMed ID: 18499573
[No Abstract] [Full Text] [Related]
6. Which antithrombotic to use during PCI?
Jolly SS; Yusuf S
Eur Heart J; 2010 Mar; 31(5):522-4. PubMed ID: 20150323
[No Abstract] [Full Text] [Related]
7. Direct thrombin inhibitors (part 2 of 2).
Arora UK; Dhir M
J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531
[No Abstract] [Full Text] [Related]
8. Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition.
Reginelli JP; Chew D
J Interv Cardiol; 2002 Apr; 15(2):141-6. PubMed ID: 12063809
[No Abstract] [Full Text] [Related]
9. Bivalirudin: role in current percutaneous coronary intervention practice.
West N
Br J Hosp Med (Lond); 2005 Dec; 66(12):687-9. PubMed ID: 16417115
[No Abstract] [Full Text] [Related]
10. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Popma JJ; Berger P; Ohman EM; Harrington RA; Grines C; Weitz JI
Chest; 2004 Sep; 126(3 Suppl):576S-599S. PubMed ID: 15383485
[TBL] [Abstract][Full Text] [Related]
11. Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.
Kwa AT; Rogers JH
J Interv Cardiol; 2008 Apr; 21(2):107-17. PubMed ID: 18248357
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
